Literature DB >> 11376123

IGF-I receptor signalling in transformation and differentiation.

B Valentinis1, R Baserga.   

Abstract

The type 1 insulin-like growth factor receptor (IGF-IR) sends several signals, some of which are contradictory. When the concentrations of insulin receptor substrate 1 (IRS-1), a major substrate of the IGF-IR, are high, the signal is mitogenic, anti-apoptotic, and can even cause malignant transformation. However, in the absence of IRS-1, the IGF-IR sends a differentiation signal, which leads to granulocytic differentiation in haemopoietic cells. The mitogenic signal of the IGF-IR/IRS-1 combination depends largely, but not exclusively, on the activation of the phosphatidylinositol-3 kinase (PI3K).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376123      PMCID: PMC1187050          DOI: 10.1136/mp.54.3.133

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  49 in total

1.  Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways.

Authors:  B Valentinis; G Romano; F Peruzzi; A Morrione; M Prisco; S Soddu; B Cristofanelli; A Sacchi; R Baserga
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

2.  Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.

Authors:  K Reiss; C D'Ambrosio; X Tu; C Tu; R Baserga
Journal:  Clin Cancer Res       Date:  1998-11       Impact factor: 12.531

Review 3.  The IRS-signalling system: a network of docking proteins that mediate insulin action.

Authors:  M F White
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

4.  Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.

Authors:  L Soon; L Flechner; J S Gutkind; L H Wang; R Baserga; J H Pierce; W Li
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts.

Authors:  J A Toretsky; T Kalebic; V Blakesley; D LeRoith; L J Helman
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.

Authors:  G Romano; M Prisco; T Zanocco-Marani; F Peruzzi; B Valentinis; R Baserga
Journal:  J Cell Biochem       Date:  1999-02-01       Impact factor: 4.429

7.  Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

Authors:  H Shima; M Pende; Y Chen; S Fumagalli; G Thomas; S C Kozma
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.

Authors:  D D Sarbassov; C A Peterson
Journal:  Mol Endocrinol       Date:  1998-12

9.  The constitutively active mutant Galpha13 transforms mouse fibroblast cells deficient in insulin-like growth factor-I receptor.

Authors:  J L Liu; V A Blakesley; J S Gutkind; D LeRoith
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

10.  The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin.

Authors:  L Yenush; C Zanella; T Uchida; D Bernal; M F White
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

View more
  84 in total

1.  History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.

Authors:  Marni Stott-Miller; Chu Chen; Shu-Chun Chuang; Yuan-Chin Amy Lee; Stefania Boccia; Hermann Brenner; Gabriela Cadoni; Luigino Dal Maso; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Keitaro Matsuo; Hal Morgenstern; Heiko Müller; Joshua Muscat; Andrew F Olshan; Mark P Purdue; Diego Serraino; Thomas L Vaughan; Zuo-Feng Zhang; Paolo Boffetta; Mia Hashibe; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

2.  EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

Authors:  Alexandre Prieur; Franck Tirode; Pinchas Cohen; Olivier Delattre
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 3.  mTOR signaling in cancer cell motility and tumor metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 4.  A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.

Authors:  Pravin T P Kaumaya
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

6.  Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

Authors:  Kerrington R Molhoek; Amber L Shada; Mark Smolkin; Sudhir Chowbina; Jason Papin; David L Brautigan; Craig L Slingluff
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

7.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

8.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

9.  Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.

Authors:  Marianna Sadagurski; Shoshana Yakar; Galina Weingarten; Martin Holzenberger; Christopher J Rhodes; Dirk Breitkreutz; Derek Leroith; Efrat Wertheimer
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.